SpaceGen and BioHandler establish comprehensive strategic partnership

SpaceGen and BioHandler establish comprehensive strategic partnership

On January 9, 2024, Shanghai BioHandler Life Sci-Tech Co., Ltd. (hereinafter referred to as "BioHandler") and Xiamen SpaceGen Co., Ltd. (referred to as "SpaceGen") signed a strategic cooperation agreement in Xiamen. SpaceGen is dedicated to providing innovative services for personalized precision medical testing in cancer, including early screening, disease diagnosis, personalized drug selection, and efficacy monitoring. BioHandler possesses extensive experience in sample pre-processing automation technology and offers multiple exclusive solutions in the life sciences field. In this collaboration, both parties will leverage their respective resources to engage in multidimensional and deep-level cooperation in the areas of fully automated intelligent testing solutions for clinical samples, clinical diagnostic products and service systems, as well as precision medical solutions.

01

In the signing ceremony, Chen Yan, the General Manager of SpaceGen, also mentioned, "SpaceGen and BioHandler each have their own advantages in their respective fields, and this collaboration allows for complementary strengths. As a molecular diagnostics company specializing in the development, production, and sales of collective external diagnostic reagents, SpaceGen has developed a series of molecular detection products for tumor diagnosis, typing, monitoring, and screening based on the NGS technology platform. BioHandler provides specialized automation solutions for NGS library preparation, efficiently automating and standardizing processes such as nucleic acid sample preparation, library construction, and library quality control. The collaboration between the two parties represents the organic integration of the genetic testing application chain, enhancing the overall strength and competitiveness of both sides in providing comprehensive solutions to users. In the future, both parties will further collaborate to explore the application and development of genetic testing products on automated library construction platforms, enriching the application value of precision diagnosis, and better providing high-quality precision diagnostic services for a wide range of cancer patients."

At the signing ceremony, BioHandler CEO Gloria Li stated, "As a leader in the 'intelligentization of the entire life science process,' BioHandler is committed to promoting the digital transformation and upgrading of the industry. Leveraging the deep cultivation and accumulation of over ten years in the field of life sciences by our seasoned founding team, we employ a design philosophy that emphasizes modularity, intelligence, and simplicity. We are dedicated to developing intelligent products with independent intellectual property rights. Clinical diagnostics is currently one of BioHandler's key business directions, and automation of sample pre-processing can effectively reduce human errors and enhance testing efficiency. Both parties will maintain a deep cooperative relationship in the direction of sample pre-processing automation in the future, providing users with more user-friendly and stable overall solutions, and striving to achieve personalized precision medicine, bringing good news to a wide range of patients."

After the signing ceremony, SpaceGen's General Manager, Chen Yan, invited the BioHandler team to visit Feishuo's research and quality control laboratory. Under the detailed explanation of the laboratory head, both parties had further in-depth communication on the implementation details of relevant application solutions and expressed confidence in future cooperation. Following the meeting, the two sides reached consensus on short-term, medium-term, and long-term cooperation goals. They agreed to collaborate closely in market expansion, leveraging complementary resources and channels to assist and support each other's brands and marketing activities, forming a united front in facing the market.

02

The BioHandler delivery to SpaceGen of the NGS fully automatic library construction system is specifically designed for next-generation sequencing (NGS) library preparation and/or nucleic acid sample targeted enrichment. It is a fully automated library construction system that eliminates the need for frequent manual replacement of consumables, enabling a truly unmanned integrated liquid handling workstation.

Xiamen SpaceGen Co., Ltd.

Benefiting Public Health

Xiamen SpaceGen Co., Ltd. was established in 2015 and is a national high-tech enterprise settled in Xiamen under the "Double Hundred Plan" for leading entrepreneurial talents. The company relies on four core technology platforms: high-throughput sequencing (NGS), digital PCR, fluorescence quantitative PCR, and nucleic acid mass spectrometry. It is committed to providing comprehensive solutions for personalized and precise diagnosis of tumors, including early screening, disease diagnosis, personalized drug guidance, and efficacy monitoring. Currently, the company has medical testing laboratories in Xiamen and Suzhou, with a 3500m² GMP production workshop and a 2000m² research/quality control laboratory. Its quality management system is certified by TUV SUD to ISO13485. SpaceGen has developed over 40 research and development products, with three products obtaining registration certificates for Class III medical devices from the National Medical Products Administration (NMPA), 10 products completing the filing for Class I medical devices, and 22 products obtaining EU CE-IVD certification.

Shanghai BioHandler Life Sci-Tech Co., Ltd.

Shanghai BioHandler Life Sci-Tech Co., Ltd. is a leading provider of intelligent solutions for the entire life science process in China. As a "leader in the intelligentization of the entire life science process," BioHandler's business covers the entire lifecycle of research and development, production, sales, and services, actively promoting the digital transformation and upgrade of the industry. With more than ten years of deep cultivation and accumulation in the field of life science, BioHandler relies on a senior founding team and adheres to the design philosophy of modularity, intelligence, and simplicity to develop intelligent products with independent intellectual property rights. As an excellent global provider of products and services for the entire life science process, BioHandler actively seizes the opportunities of the booming bioeconomy, fulfilling its mission to "praise life through technology and fulfill the promise of science." It communicates with scientists in a unified language of life science, accurately translating and transforming the needs of life science. The company has developed numerous core patented technologies, innovating in marketing management and business models. BioHandler follows the values of the "first principles, structured thinking" methodology, upholds organizational qualities of "passion, innovation, independent judgment, altruism," practices "simplify the known, explore the unknown," and insists on independent innovation to contribute to the country through science and technology. BioHandler is committed to empowering the field of life science deeply, changing the global industry landscape, building an outstanding international brand, and making Chinese innovation renowned worldwide.